Additionally, high urinary CCL2 and low urinary epidermal growth factor (EGF) levels are associated with renal tubulointerstitial fibrosis (133), suggesting that urinary CCL2 could be a useful diagnostic marker for CKD patients. Here, CCL2 is linked to chronic kidney disease.